Search Within

Daniel Eidelberg Spratt

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (15)
  2. Meeting Abstract (13)
Groups
  1. Sloan Kettering Institute Postdocs (28)
  2. Survivorship Research (21)
  3. Radiation Oncology, Department of (19)
  4. GDMT, Radiation Oncology (16)
  5. Gynecology Disease Management Team (16)
  6. Biostatistics Service (10)

More Groups

People
  1. Michael Zelefsky (21)
  2. Xin Pei (20)
  3. Marisa Kollmeier (16)
  4. Zachary Zumsteg (16)
  5. Yoshiya Yamada (12)
  6. Zhigang Zhang (10)

More People

Years
  1. 2017 (2)
  2. 2016 (2)
  3. 2015 (7)
  4. 2014 (5)
  5. 2013 (9)
  6. 2012 (3)
Publications
  1. International Journal of Radiation Oncology, Biology, Physics (14)
  2. European Urology (3)
  3. Journal of Nuclear Medicine (3)
  4. BJU International (2)
  5. Cancer Discovery (1)
  6. EJNMMI Research (1)

More Publications

Publishers
  1. Elsevier Inc. (14)
  2. Elsevier Science, Inc. (4)
  3. Society of Nuclear Medicine (3)
  4. Wiley Blackwell (2)
  5. American Association for Cancer Research (1)
  6. American Association for the Advancement of Science (1)

More Publishers

Results (28)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Predictors of castration-resistant prostate cancer after dose-escalated external beam radiotherapy
    Journal Article

    Spratt, D. E.; Zumsteg, Z. S.; Pei, X.; Romesser, P. B.; Yamada, J.; Kollmeier, M. A.; Woo, K.; Zhang, Z.; Zelefsky, M. J.
    Prostate (2015)

    Fulltext@MSK | Save
  • Annotating STEAP1 regulation in prostate cancer with (89)Zr immuno-PET
    Journal Article

    Doran, M. G.; Watson, P. A.; Cheal, S. M.; Spratt, D. E.; Wongvipat, J.; Steckler, J. M.; Carrasquillo, J. A.; Evans, M. J.; Lewis, J. S.
    Journal of Nuclear Medicine (2014)

    Fulltext@MSK | Save
  • Evaluation of PSA patterns in patients with localized prostate cancer treated with radiation therapy and androgen deprivation therapy
    Meeting Abstract

    Yang, T.; Pei, X.; Zhang, Z.; Kollmeier, M.; Spratt, D.; Zumsteg, Z.; Polkinghorn, W.; McBride, S.; Zelefsky, M.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Prostate-specific antigen bounce after dose-escalated radiation therapy for prostate cancer is an independent predictor for distant metastasis, cancer-specific survival, and overall survival
    Meeting Abstract

    Romesser, P. B.; Pei, X.; Spratt, D.; Zumsteg, Z.; Kollmeier, M. A.; Polkinghorn, W.; Zelefsky, M. J.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Cabozantinib resolves bone scans in tumor-naïve mice harboring skeletal injuries
    Journal Article

    Doran, M. G.; Spratt, D. E.; Wongvipat, J.; Ulmert, D.; Carver, B. S.; Sawyers, C. L.; Evans, M. J.
    Molecular Imaging (2014)

    Fulltext@MSK | Save
  • Comparison of high-dose (86.4 Gy) IMRT vs combined brachytherapy plus IMRT for intermediate-risk prostate cancer
    Journal Article

    Spratt, D. E.; Zumsteg, Z. S.; Ghadjar, P.; Kollmeier, M. A.; Pei, X.; Cohen, G.; Polkinghorn, W.; Yamada, Y.; Zelefsky, M. J.
    BJU International (2014)

    Fulltext@MSK | Save
  • The natural history and patterns of failure following biochemical relapse in prostate cancer (PC) patients treated with dose-escalated external beam radiation therapy (EBRT)
    Meeting Abstract

    Zumsteg, Z. S.; Spratt, D. E.; Romesser, P.; Pei, X.; Polkinghorn, W.; Kollmeier, M.; Yamada, Y.; Zelefsky, M. J.
    International Journal of Radiation Oncology, Biology, Physics (2013)

    Fulltext@MSK | Save
  • Predictors of castration resistant prostate cancer after definitive radiation therapy: Impact of failing neoadjuvant androgen deprivation therapy
    Meeting Abstract

    Spratt, D. E.; Zumsteg, Z.; Romesser, P. B.; Kollmeier, M.; Polkinghorn, W. R.; Pei, X.; Zelefsky, M. J.
    International Journal of Radiation Oncology, Biology, Physics (2013)

    Fulltext@MSK | Save
  • Comparison of high-dose IMRT (86.4 Gy) to combined brachytherapy plus IMRT for intermediate-risk prostate cancer
    Meeting Abstract

    Spratt, D. E.; Kollmeier, M.; Zumsteg, Z.; Ghadjar, P.; Yamada, Y.; Cohen, G.; Polkinghorn, W.; Pei, X.; Zelefsky, M. J.
    International Journal of Radiation Oncology, Biology, Physics (2013)

    Fulltext@MSK | Save
  • Prostate-specific antigen (PSA) doubling time at time of PSA relapse is an independent predictor for distant metastasis and survival after external beam radiation therapy
    Meeting Abstract

    Romesser, P. B.; Spratt, D. E.; Zumsteg, Z. S.; Pei, X.; Kollmeier, M. A.; Polkinghorn, W. R.; Zelefsky, M. J.
    International Journal of Radiation Oncology, Biology, Physics (2013)

    Fulltext@MSK | Save